Vitals 2023: The Pursuit of Precision Medicine


The explosion of precision medicine has produced tremendous innovation in our pursuit of addressing significant unmet medical needs across the world. Hear from industry speakers and panelists about the latest strides we’re making in precision medicine to realize the promise of individualized impact for every patient. 

Please use the following links to register for the in-person networking event and virtual conference. More details regarding location, dial-in information and logistics will be shared in the coming days. 


Thursday, February 9, 2023


Friday, February 10, 2023

Panel Discussions

   10:00 A.M. PT

  • Bruin Tank 

    This is an interactive pitch competition in which health care founders pitch their ideas to investors.

   12:00 P.M. PT

  • Making Value-Based Care Work for Precision Medicine

    Value-based care (VBC) is emerging as a transformation of the care delivery system as well as payment reform for healthcare providers and facilities. VBC puts forth the hope that value-based models are a solution to address rising costs, clinical inefficiency, and duplication of services, and to make it easier for people to get the care they need. In our panel, we will discuss the current state, future state and some of the challenges faced by Payers & Providers in adopting value-based care models for patient care.

   1:00 P.M. PT

  • Patient Data: Maximizing Returns, Minimizing Risk

    The health care industry has begun harnessing patient data to dramatically improve patient outcomes. Patient data utilization has opened the door to new scientific, clinical and business opportunities. However, there are also concerns, such as privacy risks and algorithm biases, when utilizing patient data. This panel will focus on the opportunities, trade-offs and concerns of this new landscape.

   2:00 P.M. PT

  • Precision Pharma: Targeted Therapeutics for Optimal Outcomes

    Over the past few years, we’ve seen increased integration of precision medicine practices throughout drug development. As pharmaceutical innovations create new approaches for addressing oncological, neurological, and cardiovascular, diagnoses (to name a few), patients can expect to receive an entirely new level of targeted care with increased efficacy and less side effects. In this panel, we hear from a number of pharma/biotech professionals about how their work is pushing the needle in this exciting crusade for better treatments.

About the 2023 VITALS conference

Precision medicine has seen explosive growth over the past ten years and has brought forth tremendous innovation in the pursuit of addressing significant unmet medical needs across the world. However, we’ve also seen new challenges being uncovered and limitations due to our healthcare system. At VITALS 2023, we will explore these challenges and uncover the latest strides we’re making in precision medicine to realize the promise of individualized impact for every patient. 

Start (Pacific Time)
9:30 a.m. - 10:30 a.m.
Keynote: Dr. Medell Briggs-Malonson
10:30 a.m. - 10:45 a.m.
10:45 a.m. - 11:45 a.m.
Artificial Intelligence and Machine Learning
Clinical Research
11:45 a.m. - 12:00 p.m.
12:00 p.m. - 12:45 p.m.
Fireside Chat: Rajeev Ronanki
12:45 p.m. - 1:00 p.m.
1:00 p.m. - 2:00 p.m.
FemTech and Women’s Health
On-the-Ground Operations
2:00 p.m. - 2:15 p.m.
2:15 p.m. - 3:15 p.m.
Bruin Tank
3:15 p.m. - 3:30 p.m.
3:30 p.m. - 4:15 p.m.
Keynote: Susan Tousi (’05)
4:15 p.m. - 4:30 p.m.
Closing Remarks

About the 2022 VITALS Conference


Throughout this past year, social injustices and the COVID-19 pandemic have brought issues of health inequity to light. As a result, many leaders in the health care industry are increasingly focusing their efforts to ensure people from all socioeconomic backgrounds have access to affordable health care and education. These players are seeking solutions to disparities in every facet of health care, from FemTech to large-scale diversity initiatives. At VITALS 2022, we explored what it will take to move toward a future of equitable health care. The daylong, no-cost event included keynote speakers, networking opportunities and interactive panel discussions on:

  • Achieving Inclusion in Healthcare AI Systems: Is AI contributing to inequities in healthcare, or is it a potential long-term solution? Moderated by Tony Kramer, Adjunct Professor of Decisions, Operations and Technology Management, panelists included Aalpen Patel, M.D., Medical Director for Artificial Intelligence at Geisinger and Steele Institute for Health Innovation; Ogechi Nwoko, M.D., Head of Business Development at Atman Health; Chris Hemphill, Vice President of Applied Artificial Intelligence at Actium Health; and Michael Leung, Co-Founder of Spect.
  • Diversity and Inclusion in Clinical Research: How does health equity factor into clinical research, and what is needed for long-term success? Moderated by Aman Mahajan, M.D., Ph.D., UCLA Anderson Professor, panelists included: Siavash Sarlati, M.D., Medical Director at Anthem Digital Platforms; Gregory Forlenza, M.D., Pediatric Endocrinologist at the University of Colorado Denver; Jennifer Jones-McMeans, Ph.D., Divisional Vice President of Global Clinical Affairs at Abbott; and Albert Lai, M.D. Ph.D., Professor In Residence, Neuro-oncology Program, UCLA Department of Neurology.
  • On-the-Ground Operations: What are the strategies necessary for success as companies move beyond simply setting a vision? Moderated by Paige Hosler (‘12), Division Vice President at DaVita, panelists included Kathi Cervantes, Co-Director of Community Transformation at Promesa; Jeni La, Senior Director, Value-Based Care Product Design at Envision Healthcare; Francisco Romero, Program Manager of Community Transformation at Promesa; and Myron Soyangco (‘23), Manager, Operational Excellence at Sharp HealthCare
  • Bruin Tank II: During this quick pitch competition, up-and-coming innovators pitched to investors regarding the needs of healthcare today! Founders included: Ariana Gibson, Founder and CEO of STIGMA; Christian Rivera, M.D., CEO and Co-Founder at Smart Doctor; Pedro Sanchez de Lozada, Founder and CEO of Canid; and Luke Johnson (‘21), Founder at Capex and Senior Director Business Development at American Orthopedic Partners, LLC. Investors included: Alexa Binns (‘14), Partner at Halogen Ventures; Stephanie Rich, Head of Platform at Bread and Butter Ventures; Deena Shakir, Partner at Lux Capital; and Ricardo Johnson, Head of Healthworx.
  • Women’s Health and Femtech: What are the key challenges femtech companies are facing in order to achieve meaningful progress in women’s health? Moderated by Jennifer McCaney, Ph.D., Executive Director of UCLA Biodesign and UCLA Anderson Lecturer, panelists included: Tracy MacNeal, CEO of Materna; Stasi Kasianchuk, Director of Health Coaching at Gennev; Sylvia Kang, Founder and CEO of Mira; and Pita Navarro, Head of Clinical Research and Operations at Evvy.

2021 Conference Highlights


2020 Conference Highlights


Presented by